viernes, 1 de diciembre de 2023

Groundbreaking studies indicate Semaglutide and Tirzepatide may reduce alcohol consumption in individuals with obesity

https://www.news-medical.net/news/20231201/Groundbreaking-studies-indicate-Semaglutide-and-Tirzepatide-may-reduce-alcohol-consumption-in-individuals-with-obesity.aspx

No hay comentarios:

Publicar un comentario